Idiotype-specific intravenous immunoglobulin (IVIG) for therapy of autoimmune diseases

Methods in Molecular Biology

Volumn 1060, Issue , 2014, Pages 353-361

  Blank, Miri ^a   Bashi, Tomer ^a   Shoenfeld, Yehuda ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Anti idiotype; Autoimmune disease; Immunomodulation; IVIG; Specific IVIG

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; IMMUNOGLOBULIN IDIOTYPE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; BIOTINYLATION; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PURIFICATION; CONTROLLED STUDY; EXPERIMENTAL MODEL; IMMUNOMODULATION; INFLAMMATORY DISEASE; PURIFICATION; THERAPY RESISTANCE;

ANIMALIA;

ANTIBODY SPECIFICITY; AUTOIMMUNE DISEASES; CHROMATOGRAPHY, AFFINITY; HUMANS; IMMUNOGLOBULIN IDIOTYPES; IMMUNOGLOBULINS, INTRAVENOUS;

EID: 84931273560     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-586-6_18     Document Type: Article

References (25)

1. Dwyer JM (1992) Manipulating the immune system with immune globulin. N Engl J Med 326:107-1
2. Bayry J, Thirion M, Misra N et al (2003) Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases. Neurol Sci 24:S217-S
3. Kazatchkine MD, Kaveri SV (2001) Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med 345:747-7
4. Dalakas MC (1997) Intravenous immune globulin therapy for neurologic diseases. Ann Intern Med 126:721-7
5. Sherer Y, Levy Y, Shoenfeld Y (2002) IVIG in autoimmunity and cancer-efficacy versus safety. Expert Opin Drug Saf 1:153-1
6. Kazatchkine MD (1990) Anti-idiotypic suppression of autoantibodies with high dose intravenous immunoglobulins. Prog Clin Biol Res 337:411-4
7. Omwandho CO, Gruessner SE, Roberts TK, Tinneberg HR (2004) Intravenous immunoglobulin (IVIG): modes of action in the clinical management of recurrent pregnancy loss (RPL) and selected autoimmune disorders. Clin Chem Lab Med 42:359-370
8. Sultan Y, Kazatchkine MD, Maissoneuve P, Nydegger UE (1984) Anti-idiotypic suppression of autoantibodies to factor VII (antihaemophilic factor) by high-dose intravenous immunoglobulin. Lancet 2:765-768
9. Schroeder JO, Zeuner RA, Euler HH, Löffler H (1996) High dose intravenous immunoglobulins in systemic lupus erythematosus: clinical and serological results of a pilot study. J Rheumatol 23:71-75
10. Evans MJ, Suenaga R, Abdou NI (1991) Detection and purification of antiidiotypic antibody against anti-DNA in intravenous immune globuline. J Clin Immunopathol 11:291-295
11. Rossi F, Kazatchkine MD (1989) Antiidiotypes against autoantibodies in pooled normal human polyspecific Ig. J Immunol 143: 4104-4109
12. Rossi F, Jayne DR, Lockwood CM, Kazatchkine MD (1991) Anti-idiotypes against anti-neutrophil cytoplasmic antigen autoantibodies in use and in the remission sera of patients with systemic vasculitis. Clin Exp Immunol 83: 298-303
13. Tandon N, Jayne DR, McGregor AM, Weetman AP (1992) Analysis of anti-idiotypic antibodies against anti-microsomal antibodies in patients with thyroid autoimmunity. J Autoimmun 5:557-570
14. Lundkvist I, van Doorn PA, Vermeulen M, Brand A (1993) Spontaneous recovery from the Guillain-Barre syndrome is associated with anti-idiotypic antibodies recognizing a crossreactive idiotype on anti-neuroblastoma cell line antibodies. Clin Immunol Immunopathol 67:192-198
15. Caccavo D, Vaccaro F, Ferri GM et al (1994) Anti-idiotypes against antiphospholipid antibodies are present in normal polyspecific immunoglobulins for therapeutic use. J Autoimmun 7:537-548
16. Mehta YS, Badakere SS (1996) In-vitro inhibition of antiplatelet autoantibodies by intravenous immunoglobulins and Rh mmunoglobulins. J Postgrad Med 42:46-49
17. DeKeyser F, DeKeyser H, Kazatchkine MD et al (1996) Pooled human immunoglobulins contain anti-idiotypes with reactivity against the SLE-associated 4B4 cross-reactive idiotype. Clin Exp Rheumatol 14:587-591
18. Yuki N, Miyagi F (1996) Possible mechanism of intravenous immunoglobulin treatment on anti-GM1 antibody-mediated neuropathies. J Neurol Sci 139:160-162
19. Silvestris F, Cafforio P, Dammacco F (1994) Pathogenic anti-DNA idiotype-reactive IgG in intravenous immunoglobulin preparations. Clin Exp Immunol 97:19-25
20. Evans M, Abdou NI (1993) In vitro modulation of anti-DNA secreting peripheral blood mononuclear cells of lupus patients by antiidiotypic antibody of pooled human intravenous immune globulin. Lupus 2:371-375
21. Shoenfeld Y, Rauova L, Gilburd B et al (2002) Efficacy of IVIG affinity-purified anti-doublestranded DNA anti-idiotypic antibodies in the treatment of an experimental murine model of systemic lupus erythematosus. Int Immunol 14:1303-1311
22. Blank M, AnafiL, Zandman-Goddard G et al (2007) The efficacy of specific IVIG antiidiotypic antibodies in antiphospholipid syndrome (APS): trophoblast invasiveness and APS animal model. Int Immunol 19:857-865
23. Mimouni D, Blank M, Payne AS et al (2010) Efficacy of intravenous immunoglobulin (IVIG) affinity-purified anti-desmoglein antiidiotypic antibodies in the treatment of an experimental model of pemphigus vulgaris. Clin Exp Immunol 162:543-549
24. Svetlicky N, Ortega OD, Mouthon L et al (2013) The advantage of specific intravenous immunoglobulin (sIVIG) on regular IVIG: experience of the last decade. J Clin Immunol 33(Suppl 1):S27-S32
25. Blank M, Nur I, Toub O et al (2005) Toward molecular targeting with specific intravenous immunoglobulin preparation. Clin Rev Allergy Immunol 29:213-217.